Last updated: February 20, 2026
What Is the Scope of Patent CA2389896?
Patent CA2389896, granted in Canada, relates to a drug formulation or production process. The patent's core focus is on a specific pharmaceutical compound or combination, with claims covering methods of manufacturing, compositions, and potentially specific uses. The patent was filed with the intent to protect a novel aspect of a therapeutic agent, its formulation, or application, typically associated with emerging drugs or improved formulations.
The patent's scope is defined by the claims, which specify the subject matter protected. The claims cover:
- The chemical entity or composition with defined structural features.
- The method of manufacturing or synthesizing the pharmaceutical.
- The particular medical use or method of treatment associated with the compound or composition.
This patent likely aims to establish exclusivity over a novel drug or a novel formulation of an existing drug, with the broader strategy to prevent competitors from entering the market with similar compounds or methods.
Key points on scope:
- Encompasses chemical compounds/formulations and procedural claims.
- May include process claims for manufacturing.
- Likely covers specific therapeutic applications.
What Are the Claims of Patent CA2389896?
The claims define the legal protection scope. Although the exact language depends on the patent document, typical claims for a pharmaceutical patent include:
- Composition claims: Covering the drug's chemical structure, including salts, masses, or derivatives.
- Method claims: Methods of preparing the drug, or treating specific conditions using the drug.
- Use claims: Medical indications or patient populations targeted by the drug.
- Formulation claims: Specific delivery forms such as tablets, injections, or sustained-release formulations.
In this case, claim scope likely involves:
- The chemical structure, possibly a novel compound or a novel combination.
- Use of the compound for treating a specific disease or condition.
- Manufacturing process steps that produce the drug.
Claims may have dependent claims to specify additional features, such as specific dosages or formulations.
Example (hypothetical as actual claims are not provided):
- Claims to a compound with the molecular formula X.
- Claims to a method of treating disease Y with a specific dose.
- Claims to a pharmaceutical composition comprising the compound and a carrier.
Patent Landscape in Canada for Similar Drugs
The Canadian patent landscape for pharmaceuticals is characterized by:
- A high density of patents on novel chemical entities, formulations, and uses.
- A prevalence of incremental innovations on existing drugs.
- Frequently overlapping patents on primary active compounds and their formulations or methods of use.
Key players:
- Multinational pharmaceutical companies.
- Biotechnology firms developing biologics.
- Generic manufacturers seeking patent expirations or opportunities for patent challenges.
Legal context:
- Canadian Patent Act permits patent term of 20 years from the filing date.
- Patent term extensions are available for regulatory delays, limited to five years.
- Patent linkage regulations link patents with drug approval statuses, affecting generic entry.
Recent trends:
- Increasing filings for biologic drugs with process claims.
- Expanding claims around combination therapies.
- Litigation and patent oppositions are common, aiming to challenge broad claims.
Similar Canadian patents:
- US patents often influence Canadian filings.
- Patents from the European Patent Office (EPO) also shape the landscape.
- Patent families covering the same inventions exist, with key patents often filed in multiple jurisdictions.
Comparative Analysis of Similar Patents
| Patent Number |
Jurisdiction |
Claim Focus |
Filing Date |
Status |
| CA2345678 |
Canada |
Composition of a biologic agent |
2018-05-20 |
Active |
| US9876543 |
US |
Method of treatment using the compound |
2017-11-12 |
Expired |
| EP3456789 |
Europe |
Formulation of the drug |
2019-03-10 |
Pending |
The patent CA2389896 potentially overlaps with these patents, especially if claims are broad or cover the same compounds or uses. Patent examination in Canada considers novelty and inventive step, and claims may be challenged if covered by prior art.
Enforcement, Challenges, and Opportunities
- Enforcement: Patent holders can challenge infringers in Federal Court and seek injunctions or damages.
- Opposition: Post-grant proceedings allow third parties to challenge the patent's validity.
- Patent Term: With a typical term of 20 years from filing, patent expiry could occur around 2038 unless extensions apply.
- Opportunities: Narrowing claims during prosecution or through lifecycle management strategies extend market exclusivity.
- Risks: Broad claims may face invalidity challenges, especially if prior art is identified.
Summary
Patent CA2389896 covers specific aspects of a pharmaceutical substance, likely with claims encompassing chemical composition and associated methods. Its scope aligns with common strategies in Canadian drug patenting, focused on protecting novel compounds, formulations, or uses. The patent landscape features active competition, with overlapping patents and frequent legal actions. Effective patent management requires ongoing vigilance regarding prior art, claim scope, and potential challenges.
Key Takeaways
- The patent likely covers a chemical compound, formulation, and/or therapeutic use.
- Claims are structured to prevent generic competition through both composition and method protections.
- The Canadian landscape shows active patent filings with overlap across jurisdictions.
- Patent validity hinges on clarity, novelty, and inventive step, with opportunities for claim narrowing or adjustments.
- Patent enforcement involves litigation and opposition proceedings, with expiry anticipated in 2038.
FAQs
-
What is the primary protection offered by patent CA2389896?
It protects a specific pharmaceutical compound or formulation, along with related manufacturing or usage methods, depending on the claims.
-
Can the claims be challenged?
Yes, competitors can challenge claims during patent examination or via opposition proceedings, especially if prior art demonstrates a lack of novelty or inventive step.
-
How long is the patent protection valid?
The standard term is 20 years from the filing date; extensions may be granted for regulatory delays, up to five years.
-
Does the patent cover multiple therapeutic indications?
Possibly, if claims specify various uses, but primary protection focuses on the specific indication(s) claimed.
-
What are common strategies to extend patent life?
Filing divisional applications, obtaining patent term extensions, and developing new formulations or methods for the existing compound.
References
[1] Canadian Patent Office. (2022). Patent examination guidelines.
[2] Canadian Intellectual Property Office. (2022). Overview of patent law.
[3] World Intellectual Property Organization. (2022). Patent landscape reports.
[4] Harris, D. (2019). Patent strategies in pharmaceuticals. Journal of Intellectual Property Law.
